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Transplantation of exogenous dopaminergic neuron (DA neurons) is a promising approach for treating Parkin-
son’s disease (PD). However, a major stumbling block has been the lack of a reliable source of donor DA neurons. 
Here we show that a combination of five transcriptional factors Mash1, Ngn2, Sox2, Nurr1, and Pitx3 can directly 
and effectively reprogram human fibroblasts into DA neuron-like cells. The reprogrammed cells stained positive for 
various markers for DA neurons. They also showed characteristic DA uptake and production properties. Moreover, 
they exhibited DA neuron-specific electrophysiological profiles. Finally, they provided symptomatic relief in a rat PD 
model. Therefore, our directly reprogrammed DA neuron-like cells are a promising source of cell-replacement thera-
py for PD.
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Introduction
Parkinson’s disease (PD) is a debilitating neurologi-
cal disease affecting about half a million of Americans 
with around 50 000 new diagnoses each year. At present, 
there are a variety of clinical approaches being used to 
manage the symptoms of PD at different stages, includ-
ing administration of levodopa (L-DOPA) [1, 2], or deep 
brain stimulation (DBS) where a brain pacemaker send-
ing electrical pulses to specific parts of brain is surgically 
implanted [3]. However, these treatments are mostly in-
effective for advanced-stage PD patients.
A key feature of PD is progressive degeneration and 
death of DA neurons in the substantia niagra region of 
the midbrain. One promising approach to ameliorate the 
loss of DA neurons is cell-transplantation therapy [4-8]. 
There have been numerous reports indicating that trans-
plantation of embryonic stem (ES) cells or fetal tissues 
in experimental PD animal models or human patients 
showed positive results. In most cases, ES cells or fetal 
tissue were able to migrate and integrate into the substan-
tia nigra area and provide symptomatic relief to either 
animal models or human patients of PD. Despite these 
promising results, transplantation of ES cells or fetus-
derived material has encountered formidable technical, 
legal, and religious barriers.
An exciting new source of DA neurons is the directed 
differentiation of induced pluripotent stem cells (iPSCs) 
[9-14]. Because iPSCs can be derived from adult somatic Reprogramming fibroblasts into DA neurons
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tissues and differentiated into DA neurons with efficien-
cies similar to those of ES cells, they hold great promise 
as a replacement for ES cells. However, a major hurdle 
for this approach is the carcinogenic risk of iPSCs [15, 
16]. An alternative strategy to obtain DA neurons that 
may lower carcinogenic risk is the direct conversion ap-
proach where differentiated cells (e.g., fibroblast cells) 
are directly reprogrammed into DA neurons without 
going through the fully de-differentiated iPS cell route. 
Successful direct reprogramming of mouse and human fi-
broblasts has been shown for a variety of cells including 
neurons (e.g., general neurons [17, 18], DA neurons [19, 
20], and motor neurons [21]), cardiomyocytes [22], and 
hematopoietic cells [11]. In this study, we report success-
ful reprogramming of human fibroblasts into DA neuron-
like cells with a novel set of transcriptional factors. 
These cells behaved like DA neurons morphologically 
and electrophysiologically, and could provide symptom-
atic relief in a rat model of PD. 
Results
Five transcription factors that can directly reprogram 
primary fibroblasts into DA neurons
To reprogram human fibroblasts into DA neuron-like 
cells, we compiled a list of eight transcriptional factors 
that had been demonstrated to play critical roles in DA 
neurons from various publications (Supplementary in-
formation, Table S1). These transcription factors were 
cloned into the lentiviral vector pLEX. Vectors encoding 
the transcription factors were then packaged into repli-
cation-deficient lentiviruses following established proce-
dures (see Materials and Methods section for details of 
lentivirus preparation).
We used the widely published IMR90 human fibro-
blasts as our source cells. We initially transduced all 
eight transcription factors into IMR90 cells and placed 
them onto inactivated PA6 murine feeder fibroblasts 
[23, 24]. About 10-20 days after lentiviral infection, we 
found that a significant fraction of the surviving cells be-
came elongated and developed dendrite-like protrusions 
typical of neurons (Supplementary information, Figure 
S1). Furthermore, many of the neuron-like cells stained 
positive for markers of DA neurons. Subsequently, we 
carried out a series of experiments to derive a smaller set 
of transcriptional factors that are sufficient for the mor-
phological transformation. Our efforts identified a com-
bination of five transcription factors Mash1, Ngn2, Sox2, 
Nurr1, and Pitx3 that could efficiently transform IMR90 
fibroblast cells into DA neuron-like cells following a pro-
tocol depicted in Figure 1A. Significant morphological 
transformation occurred 12-21 days after gene transduc-
tion. Interestingly, we found in our experiments that PA6 
murine feeder cells were not required for the observed 
reprogramming. In fact, using the 5-transciption factor 
(5F) protocol, we could consistently reprogram IMR90 
cells, in the absence of PA6 cells, into DA neuron-like 
cells that stained positive for the general neuron-specific 
marker Tuj1 and other markers more specifically ex-
pressed in DA neurons (Figure 1B, top panel), which 
included tyrosine hydroxylase (TH), dopa decarboxylase 
(DDC), and dopamine transporter (DAT) (see Supple-
mentary information, Table S2 for list of protein markers 
used to characterize DA neurons). In addition, these cells 
stained negative for serotonin (a marker for serotogenic 
neurons) and ChAT (a marker for cholinergic neurons), 
consistent with the reprogrammed cells being DA neu-
ron-like cells. We term these cells human-induced DA 
neuron cells (hiDA cells).
Essential requirements of Mash1, Ngn2, and Sox2 for di-
rect reprogramming of IMR90 cells into hiDA cells
Among the five factors, Mash1, Ngn2, Sox2 appeared 
to be essential, as leaving any one of them out of the 5F 
protocol abolished the reprogramming process (Supple-
mentary information, Figure S2). Mash1 appeared to be 
of critical importance, as leaving it out abolished any 
positive staining for Tuj1 or DDC staining (Supplemen-
tary information, Figure S2). This is consistent with a re-
cently published study showing that Mash1 is important 
in the conversion of mouse and human fibroblast into DA 
neuron-like cells [19]. On the other hand, leaving one or 
both of the remaining two factors (Nurr1 and Pitx3) did 
not change the frequency of morphologically changed 
cells, but appeared to attenuate the number of dendrites 
developing out of the morphologically transformed cells 
(Supplementary information, Figure S3), indicating that 
these two factors mainly function to increase the matu-
rity of the reprogrammed DA neurons.
Efficiency of reprogramming and lack of proliferation in 
hiDA cells
An important issue is the efficiency of reprogram-
ming. There appeared to be a time-dependent increase in 
cells with dendrites (neuron-like cells) and those stain-
ing positive for general and DA neuron-specific markers 
(Supplementary information, Figure S4). At day 20 after 
transduction of the five transcription factor cocktail, ap-
proximately 40% of the attached cells remaining in the 
dish stained positive for DDC, a DA neuron-specific 
marker (Figure 1B, lower panel). The other combinations 
of transcriptional factors (those with less than 5) also 
showed clear expression of DDC (Figure 1B, lower pan-
el) despite inducing cells with less dendrite and appeared www.cell-research.com | Cell Research
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to be less mature. Almost all DDC+ cells are also Tuj1+ 
and vice versa. In fact, when Tuj1+ cells were quantified, 
they exhibit an almost identical profile as DDC+ cells 
(Supplementary information, Figure S5).  It is important 
to note that many of the cells appeared to have died in 
the conversion process. By day 20 after 5F transduc-
tion, only about 2% - 4% of initially plated IMR90 cells 
survived (Figure 1C, top panel). Therefore, the overall 
frequency of fibroblast to hiDA neuron conversion was 
around 1% - 2%. The decrease in cell numbers was 
consistent with reduced BrdU labeling. In fact, 3 days 
after 5F transduction, no cells were labeled positively by 
BrdU, indicating a total lack of cell proliferation 3 days 
after 5F transduction (Figure 1C, lower panel). Further-
more, there was clear evidence for cell death in the form 
of apoptosis, as demonstrated by TUNEL staining, which 
identifies fragmented DNA in the nuclei of cells experi-
encing programmed cell death (Supplementary informa-
tion, Figure S6). The lack of cell proliferation provided 
solid evidence that the observed reprogramming did not 
go through de-differentiation and reversion to a stem or 
progenitor cell phenotype, which are usually associated 
with proliferation.
Expression levels of key DA neuron-specific genes
We next determined the expression levels of several 
DA neuron-specific genes through quantitative and semi-
quantitative RT-PCR in the hiDA cells (Figure 1D and 
see Supplementary information, Table S3 for a list of the 
primers). Our results showed clear and strong expres-
sion of DA neuron-specific genes engrailed 1(EN1), TH, 
DAT, and vesicular monoamine transporter 2 (VMAT2). 
The expression levels of these genes increased tremen-
dously (from 500-1 100-fold) in the hiDA cells when 
compared with control fibroblast cells. In fact, there was 
minimal expression of these genes in the IMR90 hu-
man fibroblasts. These data further confirmed the DA 
neuron-like identity of the hiDA cells. We also examined 
the endogenous expression of the five transcription fac-
tors used for reprogramming through semi-quantitative 
PCR using pairs of primers that each contains a primer 
specific for the endogenous gene (see Supplementary in-
formation, Table S4 for a list of the primers). Our results 
(Supplementary information, Figure S7) indicated that 
exogenous expression of the five transcription factors ac-
tivated the expression of their endogenous counterparts 
significantly.
DA uptake and production in hiDA cells
The above results clearly show that our human fibro-
blast-derived, hiDA cells express key genes expressed in 
DA neurons. While very encouraging, these results did 
not confirm the functionality of the DA neuron-like cells. 
In order to provide evidence that our hiDA cells truly be-
have like DA neurons, we measured DA uptake in these 
cells because specific, DAT-mediated dopamine uptake is 
one of the key characteristics of DA neurons. Our results 
indicated clearly that uptake of [
3H]-labeled dopamine 
in the reprogrammed putative DA-neuron cells was sig-
nificantly higher than that of parental IMR90 fibroblasts 
(Figure 2A). Supplementary information, Table S5 shows 
additional details of uptake measurements. One interest-
ing fact was that only those cells transduced with the five 
factors for more than 17 days showed specific DA uptake 
(Supplementary information, Table S5), indicating that 
the hiDA cells only exhibit dopamine uptake when they 
become more mature.
We also measured tissue levels of endogenous DA in 
hiDA cells using high-performance liquid chromatogra-
phy (HPLC). Our experiments indicated that our hiDA 
cells produced a significant amount of DA, in contrast to 
parental fibroblasts, which produced no DA (Figure 2B). 
This is consistent with the fact that DA synthesis is a key 
property of DA neurons.
DA neuron-like electrophysiology of hiDA cells
Further functional proof of the neuron-like identity 
of the hiDA cells came from whole-cell electrophysi-
ological recordings to measure voltage-gated sodium 
ion currents (Figure 3 and Supplementary information, 
Figure 1 Successful conversion of human fibroblast into hiDA cells. (A) A schematic illustration of the protocol that we used 
to transform human fibroblasts into hiDA cells. (B) Top panel: Representative micrographs of hiDA cells stained with various 
DA neuron-specific (TH, DDC, DAT), general (Tuj1), and other types of neuron (serotonin and ChAT) antibodies. DAPI stain-
ing was used to identify individual cells. Lower panel: fraction of surviving cells (stained by DAPI) that stained positive for 
DDC. The scale bars represent 200 µm. The error bars represent SEM, n = 5. M: Mash1; MS: Mash1 + Sox2; MN: Mash1 + 
Ngn2; MSN: Mash1 + Sox2 + Ngn2; MSNN: Mash1 + Sox2 + Ngn2 + Nurr1; MSNNP: Mash1 + Sox2 + Ngn2 + Nurr1 + Pitx3. (C) 
Lack of proliferation in IMR90 fibroblast cells transduced with five factors. Top panel, growth curve of 5F-transduced (IMR90 + 
5F) cells; Middle panel, fraction of cells labeled with BrdU when it was added at different times after transduction of 5F; Lower 
panel: photomicrographs of BrdU staining at day 0 and day 3 after gene transduction. The scale bars represent 200 µm. (D) 
Q-PCR analysis of key DA-neuron-specific gene expression (left panel). The right panel shows semi-quantitative PCR analy-
sis of the gene. PCR products were electrophoresed in an agarose gel and stained with EtBr. Error bars represent SEM, n = 3.www.cell-research.com | Cell Research
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Figure S8). When voltage was clamped at different hold-
ing potentials with depolarizing voltage steps (starting 
from −100 mV with successive 10 mV steps), hiDA cells 
showed a rapidly inactivating inward current (Figure 3A 
top and middle panel) at each level, followed by a non-
inactivating outward current, characteristic of typical 
neuronal voltage-gated sodium and potassium channels, 
respectively. Furthermore, when tetrodotoxin (TTX, at 
1 µM), a selective sodium channel blocker, was admin-
istered, the fast inward currents (activated at voltages 
below ENa+ = 83.5 mV) were completely blocked (Figure 
3A, lower panel), indicating that the observed currents 
were exclusively mediated through voltage-gated sodium 
channels. Furthermore, when current was clamped, pro-
longed depolarizing current injections induced typical 
neuron-like action potentials driven by sodium channels 
(Figure 3B, top panel). Moreover, these action potentials 
were again completely inhibited by TTX in the same 
cells (Figure 3B, lower panel). Overall, 39 cells were 
recorded, of which 25 cells fired and 14 did not (Supple-
mentary information, Table S6). These data provide com-
pelling evidence that our hiDA cells do possess neuron-
like sodium and potassium channels.
To establish whether hiDA cells exhibited DA release, 
whole-cell recordings were done in combination with 
the competitive DA receptor (D2R)-selective antagonist, 
raclopride [25]. The D2-autoreceptor, a receptor local-
ized on DA neurons, is well known for its involvement in 
Figure 2 Dopamine release and uptake of fibroblast-derived DA neuron-like cells. (A) Dopamine uptake in putative DA-neu-
ron cells. Cells in 12-well plates were incubated for 10 min with 50 nM [
3H]Dopamin in the absence and presence of 0.1 mM 
cocaine. Cells were then washed in ice-cold KRH buffer, lysed, and radioactivity was determined by a scintillation counter. 
Specific uptake of dopamine was calculated as the difference between measurement with and without 0.1 mM cocaine. Er-
ror bars represent SEM, n = 3. (B) Dopamine production from putative DA-neuron cells. Left panel are representative HPLC 
chromatograms showing the peaks that were detected for 10 nM DHBA and DA standard solutions (a), DHBA internal stan-
dard and endogenous DA in neurons (b), and only DHBA internal standard in fibroblasts (c). Samples were injected at time 0, 
and retention times of the standards were used to identify DHBA and DA in the tissue samples. Right panel shows quantita-
tive results of HPLC chromatography experiments measuring DA from DA-neuron like cells. Error bars represent SEM, n = 5.Reprogramming fibroblasts into DA neurons
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negative feedback regulation of DA neuronal firing [26], 
and in the presence of raclopride, greater action potential 
firing results were observed [27]. Indeed, hiDA cells that 
previously did not fire in response to repolarization fol-
lowing a hyperpolarized current step showed robust ac-
tion potential firing upon antagonist application (Figure 
3C, 40% of cells tested), consistent with DA release from 
the hiDA cells.
Furthermore, it has been established previously that 
activation of D2-autoreceptors decreases the firing and 
causes subsequent membrane hyperpolarization of re-
corded DA neurons [26, 28] and this effect is most likely 
mediated through GIRKs (G protein-coupled inward 
rectifying potassium channels) [26, 29]. Consequently, 
raclopride depolarizes the membrane potential of dop-
amine neurons [27] that should also increase the input re-
sistance [26]. Indeed, these changes were observed in the 
presence of raclopride for these hiDA cells (Figure 3D). 
To our knowledge, this is the first demonstration of func-
tional dopamine release with D2-autoreceptor expression 
in directly reprogrammed human DA cells.
Relief of PD symptoms by transplantation of hiDA cells 
in a rat model of PD
In order to evaluate the functional relevance of our 
reprogrammed DA neuron-like cells in vivo, we injected 
the reprogrammed cells into the middle of the striatum 
of an established rat model for PD (Sprague-Dawley 
rats lesioned with 6-hydroxydopamine (6-OHDA) and 
show amphetamine-induced ipsilateral rotations). Our 
data indicate that compared with controls, which were 
6-OHDA lesioned rats injected with saline, those injected 
with hiDA cells showed a significant stabilization of 
their rotational behaviors while those injected with saline 
showed progressively worse rotational behaviors (Figure 
4A). When individual rats were examined, four of eight 
rats injected with cells showed attenuated rotational be-
havior at 8 weeks post injection (Figure 4B).
To show evidence of long-term engraftment, we sac-
rificed two rats that showed improvement at 16 weeks 
after hiDA cellular transplantation and examined their 
brain tissues by immunofluorescence staining. Our re-
sults indicate clear evidence for the presence of human 
cells, as demonstrated by positive staining for a human 
nuclear protein (HN, Figure 4C). These cells also showed 
clear staining for TH, DDC, and DAT, indicating that 
they retained their DA neuron-like properties in vivo for 
up to 16 weeks post transplantation.
Discussion
The advent of iPSC renewed hopes for cell-replace-
ment therapy for PD. It is now possible to derive an 
unlimited number of pluripotent stem cell from either 
skin or other somatic tissues. Indeed, it has been shown 
that much like ES cells, iPS cells could be differentiated 
into DA neuron-like cells and these cells could provide 
symptomatic relieve in rodent models of PD (iPS cells 
[12] and ES cells [30]). In addition, because iPS cells 
are derived from the patients’ own cells, they should not 
elicit an immunogenic response when transplanted back 
into the patients’ brain, as is likely with transplantation of 
donor fetal tissues. Despite these significant advantages, 
there exists a significant hurdle before patient-derived 
iPS cells could be evaluated in human patients. Because 
of the use of genes such as Oct4 and Myc, which are 
known to promote carcinogenesis, there is a clear risk 
that there may exist a small number of cells that may be-
come oncogenic during the iPSC induction process [12, 
31]. Therefore, for any iPSC-derived cell-replacement 
treatment to be evaluated in humans, technological ad-
vances have to be made to reduce the carcinogenic risks 
of iPSCs significantly.
Direct-reprogramming approaches avoid much of 
the carcinogenic risks of the iPSC approach because 
differentiated cells (including both the starting and con-
verted cells here) are less likely to form tumors when 
transplanted in vivo. However, in its current form most 
direct-reprogramming approaches still use lentiviral vec-
tors, which carry inherent risks of genome integration 
and inactivation of key tumor suppressor genes that may 
lead to tumor formation, albeit at much lower risks than 
the iPSC-associated methods. In the regard, promising 
alternative gene transduction approaches, such as RNA-
based approach, have shown that lentiviral vectors could 
be replaced all together [32, 33], thereby reducing much 
of the remaining risks for carcinogenesis in direct con-
version of differentiated cells into DA neurons or other 
differentiated cell lineages.
Recently, there has been a wave of publications that 
report successful direct reprogramming of fibroblasts 
into neurons. The earliest of these is the successful con-
version of mouse fibroblasts into induced neurons (iNs) 
using three transcription factors Ascl1 (Mash1), Brn2, 
and Myt1l by Vierbuchen et al. [17]. The same group 
also showed that the above three factors could convert 
human fibroblasts into neurons when combined with 
an additional transcription factor NeuroD1 [18]. These 
cells showed morphological and electrophysiological 
behaviors that are typical of neurons. However, the ex-
act identities of the converted neurons were not clear 
and they clearly lacked signatures of DA neurons. Us-
ing two of the above three transcription factors (MYT1L 
and BRN2) but with the addition of a microRNA (miR-www.cell-research.com | Cell Research
Xinjian Liu et al.
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Figure 3 Electrophysiological profiles of putative hiDA neurons. (A) Whole-cell membrane currents from a representative 
DIV12 cell held at an initial holding potential of −70 mV was first hyperpolarized to −100 mV before successive 10 mV steps 
were delivered (average of 5 repetitions at a rate of 1 Hz). Fast, rapidly inactivating inward current, detailed in inset, was fol-
lowed by a non-inactivating outward current. Fast inward currents were quantified from another cell (DIV11), isolated with 
cesium-based electrode solution to demonstrate expected ENa+ of +83.5 mV and were completely blocked by TTX (1 µM). 
Symbols ± SEM bars represent the mean of y-axis currents (pA) in the presence and absence of TTX. (B) Current clamp re-
cording in which current injections maintained a starting voltage of −70 mV, followed by a hyperpolarizing current step (−40 
pA) and successive 30 pA steps. In response, a typical DIV13 cell demonstrated fast, rapidly inactivating voltage spikes upon 
depolarizing current injections, which were also sensitive to TTX (1 µM). These are typical of DA neuron action potentials. (C) 
Overlay of two consecutive whole-cell recording events shown in a representative DIV21 cell before and after application of the D2-
receptor selective antagonist (raclopride, 1 µM). Action potentials resulted after a hyperpolarizing step (−40 pA) in the presence of 
the antagonist. (D) In the every cell assessed, the membrane potential was significantly depolarized in the presence of raclopride (5 
cells, mean ± SEM (mV) *P < 0.05, **P < 0.001, paired Student’s t-test) compared to baseline control. The input resistance similarly 
increased in the presence of raclopride for each cell, suggesting D2-autoreceptor antagonism (5 cells, mean ± SEM (MΩ) *P < 0.05, 
**P < 0.001, paired Student’s t-test, input resistance baseline control versus raclopride for each cell).Reprogramming fibroblasts into DA neurons
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Figure 4 In vivo cell transplantation studies with reprogrammed DA neuron-like cells. (A) About 3 × 10
5 reprogrammed cells (12 
days post infection) were injected into the middle of striatum of rats to the side with 6-OHDA-induced lesions with a Hamilton 
syringe. Right before and at different times after cell transplant, rats were evaluated for amphetamine-induced rotational be-
havior with a rotometer. Error bars represent SEM, n = 8. (B) Rotational behaviors of four 6-OHDA-lesioned rats injected with 
hiDA cells. (C) Brain tissues from the two rats that showed consistent correction of amphetamine-induced rotational behav-
iors were examined for evidence of transplanted cells through immunoflurescenece. HN: staining for human nuclear protein, 
which is an indicator of injected human cells. Scale bars represent 200 µm.www.cell-research.com | Cell Research
Xinjian Liu et al.
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124), Ambasudhan et al. [34] showed that it is possible 
to convert human fibroblast cells into functional neurons. 
Again, these neurons, despite being functional, are not 
clearly defined in their subtypes. Similarly, Yoo et al. [35] 
showed that it is possible to convert human fibroblasts 
into neurons with microRNAs miR-9/9*, miR-124 in 
combination with NeuroD2. Qiang et al. [36] showed 
that it is possible to directly convert fibroblasts from 
patients with Alzheimer’s diseases into functional glut-
matergenic forebrain neurons with transcription factors 
Ascl1, Brn2, Zic1, and Myt1l. Several of these protocols 
appear to confirm the importance of Ascl1 (Mash1) in the 
reprogramming of fibroblasts into neurons, which was 
also proved important in our study.
More recently, two reports showed successful direct 
conversion of DA neuron-like cells in mouse [19] and 
human fibroblasts [19, 20]. Of these, Caiazzo et al. [19] 
used transcription factors Ascl1 (Mash1), Nurr1, and 
Lmx1a. In the second report, Ascl1, Brn2, and Mytl were 
used in combination with Lmx1a and FoxA1 [20]. Both 
reports showed DA neuron-like cellular morphology and 
electrophysiology. However, our hiDA cells appear to be 
more morphologically mature when compared with those 
reported in those two reports. Furthermore, compared 
with our study, only limited in vivo evaluation, in the 
form of injection and examination of brain slices shortly 
afterwards (4 days), was done in the report from Caiazzo 
et al. [19], and no in vivo characterization was carried 
out in the report of Pfisterer et al. [20]. No functional 
evaluation was carried out in rats with PD symptoms. In 
comparison, our study involves in vivo functional studies 
in PD rats over an extended period of time.
In summary, results from this study suggest that our 
5F cocktail can successfully reprogram human fibroblast 
cells into DA neuron-like cells. These cells behave like 
DA neuron cells both morphologically and functionally. 
Aside from adding to an increasing collection of success-
ful and exciting direct cellular-reprogramming stories 
[17-19, 22, 34, 37, 38], the main implication for our dis-
covery is a potentially safe strategy to derive DA neuron-
like cells for treatment of PD, a devastating neurological 
disease with no universally satisfactory treatment strat-
egy currently available. Because these cells are of human 
origin and could be obtained with robust efficiency, we 
believe that they provide a promising source of DA neu-
rons for evaluation as potential treatments for PD.
Materials and Methods
Cell culture
Early passage human fibroblasts IMR90 (from fetal lung), were 
obtained from the Coriell Institute for Medical Research (Camden, 
NJ, USA). They were maintained in standard medium (MEM + 
non-essential amino acid + 10% bovine serum) and sub-cultured 
every 3-5 days as necessary. To induce DA neuron-like cells, we 
used DMEM/F12 medium (Fisher) with B27 supplement (Invit-
rogen), 25 ng/ml Sonic Hedgehog (SHH, R&D), 25 ng/ml FGF-8 
(R&D), and non-essential amino acid (Fisher).
Plasmid cloning and lentivirus production
From published literature, we selected a list of eight transcrip-
tional factors that were shown to carry out critical roles in DA 
neurons (Supplementary information, Table S1). We then obtained 
cDNAs encoding the factors from Open Biosystems (Huntsville, 
AL, USA). Brief descriptions of each of the selected transcrip-
tion factors were included in Supplementary information, Table 
S1. The ORF of the transcription factors were transferred into the 
pLEX lentiviral vectors (Open Biosystems, Huntsville, AL, USA) 
by combined use of PCR and subcloning.
Lentiviral packaging plasmids, psPAX2 and pMD2.G, were 
obtained from Addgene (Cambridge, MA, USA). These plasmids 
were originally deposited to Addgene by Dr Didier Trono of EPFL 
(Ecole Ploytechnique Fédérale de Lausanne, Switzerland).
To produce lentiviral vectors encoding various transcription 
factors, lentiviral plasmids encoding the individual transcription 
factors were transduced into 293T cells together with second-
generation packaging plasmids from the Trono laboratory (psPAX2, 
pMD2.G) [39] following a published, calcium phosphate-based 
Trono lab protocol (http://tronolab.epfl.ch/page58122.html). Su-
pernatants were collected 48 h after transfection. The supernatants, 
which contain active recombinant lentiviral vectors, were then 
used in subsequent gene transduction experiments.
Lentivirus transduction
Fibroblasts at the exponential phase of growth were infected 
with a cocktail of lentiviral vector supernatants with polybrene 
(10 µg/ml). At 24 h after infection, infected fibroblast cells were 
trypsinized and replated into a 10-cm Petri dish at a density of 3 
× 10
6 cells or into a 12-well plate at 2.5 × 10
5 cells/well or into a 
24-well plate at 1.5 × 10
5 cells with polybrene free medium. 24 
h later, the medium was changed to DMEM/F12 medium (1:1) 
containing B27 supplement (Invitrogen), 25 ng/ml
 SHH (R&D), 
and 25 ng/ml FGF8 (R&D). Medium was changed every 48 h sub-
sequently. Under some circumstances, putative dopamine neuron-
like cells were also digested with Accutase (Gibco) for transferring 
to a new Petri dish or culturing plates.
Immunofluorescence staining
For immunofluorescence staining, cells were washed twice with 
phosphate-buffered saline (PBS) and fixed with 4% paraformalde-
hyde for 10 min, washed twice with PBS and then blocked for 45 
min at room temperature with PBS containing 1% bovine serum 
albumin and 0.1% Triton X-100. Primary antibodies were used at 
dilutions recommended by the manufacturer. The antibodies (anti-
human in all cases) used were mouse anti-Tuj1 (Covance, 1:800), 
rabbit anti-TH (Pel-Freez, 1:1 000), rat anti-DAT (Chemicon, 
1:5 000), rabbit anti-DDC (Chemicon, 1:500), rat anti-Serotonin 
(Chemicon, 1:200), goat anti-ChAT (Chemicon, 1:100), mouse an-
ti-HN (Millipore, 1:200). Secondary antibodies labeled with either 
Alexa488 or Alexa555 were obtained from Invitrogen (Carlsbad, 
CA, USA). In all cases, cellular nuclei were stained with DAPI in 
VectorShield mounting medium (Vector Laboratories, Burlingame, Reprogramming fibroblasts into DA neurons
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Calculation of transduction efficiency
To calculate the efficiency of neuronal induction, the average 
number of neuron-specific marker-positive cells present in DAPI-
positive cells of 10 randomly selected ×20 visual fields was used 
to determine the fraction of total number of neurons present. The 
total numbers of cells were determined using cells cultured in par-
allel wells or dishes.
Real-time PCR and PCR
Total RNA was extracted using RNAeasy Mini Kit (Qiagen) 
according to the manufacturer’s instructions. RNA was then sub-
jected to complementary DNA synthesis with random hexamer 
primers using Superscript III reverse transcriptase (Invitrogen). 
Quantitative real-time PCR was performed using SYBR Green 
PCR Master Mix (Qiagen). A full description of primer sequence 
can be found in Supplementary information, Tables S3 and S4.
Quantification of tissue dopamine (DA) levels
We used a previously published method to quantify tissue 
DA levels [40]. Media was removed from the wells and replaced 
with 100 µl of 0.1 M HClO4 solution containing 7.9 mM sodium 
metabisulfite and 1.3 mM EDTA, as well as 10 nM dihydroxyben-
zylamine (DHBA) as an internal standard. The cells were removed 
by scrapping, and the wells were washed with an additional 100 
µl HClO4 solution. Samples were either pooled from all wells for 
assay, or assayed individually. Cellular suspensions (200 µl) were 
sonicated and centrifuged for 15 min at 13 000× g and 4 °C. Sam-
ples were filtered (0.22 µm), and 50 µl aliquots were subjected to 
HPLC analysis. The HPLC consisted of an ESA Coulochem III 
EC detector with a model 5011A analytical cell (guard cell = 300 
mV, E1 = −100 mV, E2 = + 220 mV) (ESA Analytical, Chelms-
ford, MA, USA) and a Brownlee Velosep RP-18 3-µm column 
(Perkin Elmer, Chelton, CT, USA). The mobile phase consisted 
of 150 mM NaH2PO4, 4.76 mM citric acid, 50 µM EDTA, 25 mM 
SDS, 20% methanol and 17% acetonitrile (pH 5.6). Flow rate was 
0.6 ml/min. All chemicals were purchased from Sigma-Aldrich, St 
Louis, MO, USA.
[
3H]DA uptake assay
A previously published method [41] was used. Medium was re-
moved from cells that were grown on a 12-well plate and replaced 
with KRH buffer (120 mM NaCl, 10 mM HEPES, 10 mM glu-
cose, 4.7 mM KCl, 2.2 mM CaCl2, 1.2 mM MgSO4, and 1.2 mM 
KH2PO4, pH 7.4) supplemented with 0.01 mM pargyline, ascorbic 
acid and catechol. Specific uptake of 50 nM [
3H]DA was then 
measured for 10 min at 37 °C as the difference between uptake 
in the absence and presence of 0.1 mM cocaine (~3 wells/condi-
tion/cell type; assay volume = 1 ml). The assay was terminated by 
quickly washing the cells three times with 1 ml of ice-cold KRH 
buffer. Cells were then lysed with 0.5 ml 5% trichloroacetic acid 
for 60 min with gentle shaking before a 0.1 ml aliquot was added 
to 4 ml of scintillation cocktail. Radioactivity was determined by 
liquid scintillation spectrometry.
Whole-cell electrophysiological recordings
Whole-cell, patch-clamped recordings were conducted on 
visually identified cells at DIV11-21 using infrared differential 
interference contrast optics as previously described [42]. Borosili-
cate glass recording electrodes (Harvard Instruments, Holliston, 
MA, USA) were pulled to a resistance of 5-9 MΩ using a Sutter 
P-97 electrode puller (Sutter Instruments, Novato, CA, USA). For 
voltage-clamped recordings, the internal patch solution comprised 
135 mM K-gluconate (interleaved with 135 mM CsMeSO4), 10 
mM HEPES, 10 mM EGTA, 0.4 mM Na
+-GTP, 4 mM Na
+-ATP, 1.5 
mM NaCl2, 1 mM MgCl2, 5 mM glucose, pH adjusted to 7.35 with 
1 M KOH (or CsOH), with an osmolarity of 316 mOsm. Current-
clamped recordings were obtained with the above internal patch 
solution consisting of 135 mM K-gluconate. The external record-
ing solution was comprised of 140 mM NaCl2, 6 mM KCl, 10 mM 
HEPES, 15 mM D-glucose, 1.5 mM CaCl2, 1 mM MgCl2, pH ad-
justed to 7.34 with NaOH at 312 mOsm. TTX (1 µM) was added 
in some experiments to the extracellular solution to block voltage-
gated sodium channels. All salts and drugs were purchased from 
Sigma Aldrich (St Louis, MO, USA). Membrane potentials were 
maintained at −70 mV, and voltage steps were delivered from a 
hyperpolarized potential of −100 mV to −110 mV and subsequent-
ly depolarized with 10 mV steps up to either 10 mV or 80 mV at a 
rate of 1 Hz for up to seven repetitions. Action potentials were re-
corded by current injection to maintain an initial holding potential 
of approximately −70 mV and then a hyperpolarizing current step 
was delivered (−40 pA), with subsequent 30 pA depolarizing steps 
up to 100 pA at a rate of 1 Hz up to seven repetitions. In a subset 
of experiments, successive traces were recorded every 10 s in or-
der to monitor the membrane-holding potential and the input resis-
tance up to 5 min. At the start of each trace, the membrane poten-
tial was hyperpolarized (−40 pA) from a starting potential near rest 
(baseline current adjusted but maintained during the experiment to 
achieve a membrane potential between −60 and −80 mV). Altera-
tions in membrane potential and input resistance in the presence of 
the D2 receptor antagonist raclopride (1 µM) were also recorded 
up to 5 min. Additionally, series resistance and membrane capaci-
tance cancellations were performed for all cells larger than Rinput = 
1 GΩ. For voltage-clamp recordings in the presence of cesium, no 
resting membrane potential was recorded. Responses were ampli-
fied and filtered (Axopatch 200B, MDS, Sunnyvale, CA, USA) as 
previously described [42].
Electrophysiological analysis
Responses were measured and analyzed using the software 
pClamp version 8.2 (MDS, Sunnyvale, CA, USA). Voltage-
clamped traces were averaged at each holding potential across 
repetitions and initial baseline was consistently set between 56.5 
ms and 106.5 ms at −70 mV. For I-V (current-voltage) plots, am-
plitudes were measured by averaging at the peaks of both inward 
and outward current. Current amplitudes were subsequently plot-
ted with respect to the voltage at which currents were obtained. 
Amplitudes originating from the same voltage step were then av-
eraged, and error bars represent the mean amplitude ± SEM for a 
given voltage. To assess D2-autoreceptor antagonism, membrane-
holding potential was averaged by selecting multiple points over 
a time course of 40 s up to 2 min for a control baseline. The same 
was done in the presence of raclopride, and the baseline difference 
was calculated per cell. Input resistance measurements were based 
on dV/dI per baseline of each cell. Membrane potential and input 
resistances before and during drug (raclopride, 1 µM) application 
were compared for each cell with paired Student’s t-test. Passive www.cell-research.com | Cell Research
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membrane properties were additionally assessed in which n = 
number of recordings from individual cells and were expressed as 
mean ± SEM.  Mann-Whitney Rank Sum tests were performed for 
two group comparisons. Statistical significance was set at P ≤ 0.05 
(Sigmaplot, Systat, Point Richmond, CA, USA).
Transplantation of cells into a rat model of Parkinson’s dis-
ease
We followed a previously established cellular transplant pro-
tocol [43]. Sprague-Dawley rats (3 months of age from Taconic) 
were unilaterally lesioned in the medial forebrain bundle (stereo-
taxic coordinates from Bregma were AP − 4.3, ML + 1.2, DV − 
8.3) with 6-hydroxydopamine (2 µg/µl infused at a rate of 1 µl/
min over 4 min). The rats were evaluated for completeness of the 
lesion by their rotational behavior in response to D-amphetamine. 
The animals were placed in a rotometer (San Diego Instruments) 
and the rotational behavior in response to D-amphetamine (5 mg/
kg) was recorded quantitatively for 18 consecutive 5-min periods 
(90 min total).
Reprogrammed DA cells were transplanted into the middle of 
the striatum using stereotaxic surgery (coordinates from Bregma 
AP + 0.5, ML + 2.5, DV − 5.0). Cells were implanted using a 
Hamilton syringe (3 µl of concentration = 10
5 cells/µl at a rate of 
1 µl/min).  At 4 weeks, 8 weeks, and 12 weeks after implantation, 
the animals were tested for rotational behavior in response to D-
amphetamine as previously described.
Animals were sacrificed at the conclusion of the study by bar-
biturate overdose and perfused with 4% paraformaldehyde. Brains 
were removed and post-fixed in 4% paraformaldehyde overnight 
and subsequently immersed in 30% sucrose.  Fixed tissue was 
sectioned in the coronal plane on a freezing microtome at 30 µm 
thickness and subsequently processed for immunofluorescence and 
immunohistochemistry. Staining of the tissue sections for tyrosine 
hydroxylase, dopamine transporter, and human nuclei antibodies 
was performed as markers of the implanted cells.
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